China NMPA Product Recall - Optiform Prosthetic Heart Valve

Corcym S.r.1., an artificial heart valve manufacturer, in collaboration with Corcym Medical Technology (Shanghai) Co., Ltd., has initiated a voluntary Class I recall of its Optiform Prosthetic Heart Valve. This action, publicly announced on March 28, 2025, by the National Medical Products Administration (NMPA) in China, addresses a critical manufacturing concern. The primary issue identified is a potential deficiency in the thickness of the pyrolytic carbon coating on the valve leaflets, which does not meet the specified product standards. The Optiform Prosthetic Heart Valve is registered under National Medical Device Registration Certificate No. 20163132339. A Class I recall indicates the highest level of risk, signifying a reasonable probability that using the product could lead to serious adverse health consequences or even death. Although no specific inspection dates are mentioned, this recall is a proactive measure undertaken by the company to ensure patient safety. All affected unused products have been successfully isolated and secured within company warehouses. Detailed information, including specific models, specifications, and batch numbers of the impacted devices, is provided in the accompanying "Medical Device Recall Event Report Form." This recall emphasizes the continuous need for rigorous quality control in medical device production to comply with NMPA regulations.